Ustekinumab Supplier-Buyer Network — Trade Flow Analysis

Name: Ustekinumab Supplier-Buyer Trade Network Dataset — 23+ Indian Exporters, 16+ Importers, 10+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Ustekinumab supplier network, Ustekinumab buyers, pharmaceutical export India, Ustekinumab trade data

TransData Nexus

Ustekinumab

India Pharmaceutical Trade Intelligence

$1.3M23 Suppliers10 CountriesHS 30021500

ExportsIndia → BRAZIL71.5%India → JAPAN12.6%

ImportsNETHERLANDS → India$1.5M UNITED STATES → India$1.1M

#1 Supplier: NIVIRA EXPORTS #1 Buyer: AS PER

Who Supplies Ustekinumab? Top Manufacturers & Buyers 2026 — NIVIRA EXPORTS Leads | TransData Nexus | TransData Nexus

1GNH INDIA PHARMACEUTICALS LIMITED

GNH INDIA PHARMACEUTICALS LIMITED is the first-largest Ustekinumab exporter from India, with a market share of 15.4% and a total export value of $196.0K across 33 shipments. Their average shipment value of $5.9K is above the market average of $4.6K, suggesting premium or bulk contract pricing.

GNH INDIA PHARMACEUTICALS LIMITED serves 5 named buyers in our database. TO THE ORDER, is the dominant customer, accounting for 54.4% of this supplier's tracked business. Top customers include:

• TO THE ORDER, — $106.7K across 18 shipments (54.4% of this supplier's total exports)

• TO THE ORDER, — $62.5K across 11 shipments (31.9% of this supplier's total exports)

• TO THE ORDER, — $9.1K across 2 shipments (4.6% of this supplier's total exports)

• TO THE ORDER, — $8.9K across 1 shipments (4.5% of this supplier's total exports)

Key Insight: GNH INDIA PHARMACEUTICALS LIMITED's per-shipment value of $5.9K is 29% above the market average of $4.6K, consistent with large-order contracts or value-added formulations.

2BIOCON BIOLOGICS INDIA LIMITED

BIOCON BIOLOGICS INDIA LIMITED is the second-largest Ustekinumab exporter from India, with a market share of 12.6% and a total export value of $160.7K across 5 shipments. Their average shipment value of $32.1K is above the market average of $4.6K, suggesting premium or bulk contract pricing.

BIOCON BIOLOGICS INDIA LIMITED serves 4 named buyers in our database. SHIMA HIROMI is the dominant customer, accounting for 65.8% of this supplier's tracked business. Top customers include:

• SHIMA HIROMI — $105.7K across 3 shipments (65.8% of this supplier's total exports)

• XXSHIXXO IXX — $27.5K across 1 shipments (17.1% of this supplier's total exports)

• Naoko Shioji — $27.4K across 1 shipments (17.1% of this supplier's total exports)

• XXITHXXS MXXICAXXDEV — $8 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: BIOCON BIOLOGICS INDIA LIMITED's per-shipment value of $32.1K is 597% above the market average of $4.6K, consistent with large-order contracts or value-added formulations.

3NIVIRA EXPORTS

NIVIRA EXPORTS is the third-largest Ustekinumab exporter from India, with a market share of 10.8% and a total export value of $137.3K across 61 shipments. Their average shipment value of $2.3K is below the market average of $4.6K, reflecting a high-volume, competitive pricing strategy.

NIVIRA EXPORTS serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TO THE CONCERN PERSON — $56.2K across 25 shipments (41.0% of this supplier's total exports)

• NEUSA ALVES DA SILVA — $29.7K across 13 shipments (21.7% of this supplier's total exports)

• ISIS DE OLIVEIRA MELO FELTRIN — $24.1K across 11 shipments (17.5% of this supplier's total exports)

• FABIO ROSA VACCARI — $15.0K across 7 shipments (10.9% of this supplier's total exports)

• SARAH CRISTINA DIAS RIBEIRO — $12.2K across 5 shipments (8.9% of this supplier's total exports)

Key Insight: NIVIRA EXPORTS operates with high shipment frequency (61 shipments) at a per-shipment value of $2.3K, indicating a broad distribution network with many smaller, regular orders.

4VAMA LIFECARE PRIVATE LIMITED

VAMA LIFECARE PRIVATE LIMITED is the fourth-largest Ustekinumab exporter from India, with a market share of 9.9% and a total export value of $126.1K across 55 shipments. Their average shipment value of $2.3K is below the market average of $4.6K, reflecting a high-volume, competitive pricing strategy.

VAMA LIFECARE PRIVATE LIMITED serves 5 named buyers in our database. AS PER INVOICE BRAZIL is the dominant customer, accounting for 89.0% of this supplier's tracked business. Top customers include:

• AS PER INVOICE BRAZIL — $112.2K across 49 shipments (89.0% of this supplier's total exports)

• AS PER INVOICE AS — $4.9K across 2 shipments (3.9% of this supplier's total exports)

• AS PER INVOICE — $3.8K across 2 shipments (3.0% of this supplier's total exports)

• EXP CODE — $2.6K across 1 shipments (2.1% of this supplier's total exports)

• TO THE — $2.5K across 1 shipments (2.0% of this supplier's total exports)

Key Insight: VAMA LIFECARE PRIVATE LIMITED operates with high shipment frequency (55 shipments) at a per-shipment value of $2.3K, indicating a broad distribution network with many smaller, regular orders.

5R B INTERNATIONAL

R B INTERNATIONAL is the fifth-largest Ustekinumab exporter from India, with a market share of 5.9% and a total export value of $74.6K across 14 shipments. Their average shipment value of $5.3K is above the market average of $4.6K, suggesting premium or bulk contract pricing.

R B INTERNATIONAL serves 2 named buyers in our database. NA is the dominant customer, accounting for 87.7% of this supplier's tracked business. Top customers include:

• NA — $65.4K across 12 shipments (87.7% of this supplier's total exports)

• EDUARDO HENRIQUE OSO — $9.2K across 2 shipments (12.3% of this supplier's total exports)

Key Insight: R B INTERNATIONAL's per-shipment value of $5.3K is 15% above the market average of $4.6K, consistent with large-order contracts or value-added formulations.

6AMERICAN MIDDLE EASTERN MEDICAL SOLUTIONS PRIVATE

AMERICAN MIDDLE EASTERN MEDICAL SOLUTIONS PRIVATE is the fifth-largest Ustekinumab exporter from India, with a market share of 4.5% and a total export value of $57.9K across 7 shipments. Their average shipment value of $8.3K is above the market average of $4.6K, suggesting premium or bulk contract pricing.

AMERICAN MIDDLE EASTERN MEDICAL SOLUTIONS PRIVATE serves 2 named buyers in our database. TO THE ORDER OF is the dominant customer, accounting for 76.6% of this supplier's tracked business. Top customers include:

• TO THE ORDER OF — $44.3K across 5 shipments (76.6% of this supplier's total exports)

• KING ABDUL AZIZ MEDI — $13.6K across 2 shipments (23.4% of this supplier's total exports)

Key Insight: AMERICAN MIDDLE EASTERN MEDICAL SOLUTIONS PRIVATE's per-shipment value of $8.3K is 79% above the market average of $4.6K, consistent with large-order contracts or value-added formulations.

1Brazil

Brazil ranks as the first-largest destination for Ustekinumab imports from India, with a total trade value of $909.9K across 77 shipments — representing a 71.5% share of all Ustekinumab exports. The average shipment value of $11.8K is above the global average of $4.6K, indicating high-value procurement contracts or branded formulations. This market is served by 7 tracked buyers.

Named Ustekinumab importers in Brazil: AS PER INVOICE BRAZIL is the largest buyer, accounting for 12.3% ($112.2K) of this market's total imports.

• AS PER INVOICE BRAZIL — $112.2K (12.3% of Brazil's total)

• TO THE CONCERN PERSON — $56.2K (6.2% of Brazil's total)

• NEUSA ALVES DA SILVA — $29.7K (3.3% of Brazil's total)

Key Insight: Brazil's per-shipment average of $11.8K (156% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Brazil is a key market for Ustekinumab imports from India.

Primary Market

Secondary Market

2Japan

Japan ranks as the second-largest destination for Ustekinumab imports from India, with a total trade value of $160.7K across 2 shipments — representing a 12.6% share of all Ustekinumab exports. The average shipment value of $80.3K is above the global average of $4.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Ustekinumab importers in Japan: SHIMA HIROMI is the largest buyer, accounting for 65.8% ($105.7K) of this market's total imports.

• SHIMA HIROMI — $105.7K (65.8% of Japan's total)

Key Insight: Japan's per-shipment average of $80.3K (1642% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Japan is a key market for Ustekinumab imports from India.

Primary Market

Secondary Market

3Saudi Arabia

Saudi Arabia ranks as the third-largest destination for Ustekinumab imports from India, with a total trade value of $125.8K across 2 shipments — representing a 9.9% share of all Ustekinumab exports. The average shipment value of $62.9K is above the global average of $4.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Ustekinumab importers in Saudi Arabia: TO THE CONSIGNEE- is the largest buyer, accounting for 37.0% ($46.6K) of this market's total imports.

• TO THE CONSIGNEE- — $46.6K (37.0% of Saudi Arabia's total)

Key Insight: Saudi Arabia's per-shipment average of $62.9K (1264% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Saudi Arabia is a key market for Ustekinumab imports from India.

Primary Market

Secondary Market

4Turkey

Turkey ranks as the fourth-largest destination for Ustekinumab imports from India, with a total trade value of $36.9K across 3 shipments — representing a 2.9% share of all Ustekinumab exports. The average shipment value of $12.3K is above the global average of $4.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Ustekinumab importers in Turkey: IMPORT MANAGER INTERNATIONAL SALES CO is the largest buyer, accounting for 59.8% ($22.1K) of this market's total imports.

• IMPORT MANAGER INTERNATIONAL SALES CO — $22.1K (59.8% of Turkey's total)

Key Insight: Turkey's per-shipment average of $12.3K (167% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Turkey is a key market for Ustekinumab imports from India.

Primary Market

Secondary Market

5United Arab Emirates

United Arab Emirates ranks as the fifth-largest destination for Ustekinumab imports from India, with a total trade value of $19.1K across 3 shipments — representing a 1.5% share of all Ustekinumab exports. The average shipment value of $6.4K is above the global average of $4.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Ustekinumab importers in United Arab Emirates: DAWAA DRUG STORE LLC is the largest buyer, accounting for 93.8% ($17.9K) of this market's total imports.

• DAWAA DRUG STORE LLC — $17.9K (93.8% of United Arab Emirates's total)

Key Insight: United Arab Emirates's per-shipment average of $6.4K (38% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Arab Emirates is a key market for Ustekinumab imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Ustekinumab.
2.Flow Mapping: 23 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 276 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 10 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

276 Verified Shipments

23 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Ustekinumab

Ustekinumab

Who Supplies Ustekinumab? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Ustekinumab? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Ustekinumab Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1GNH INDIA PHARMACEUTICALS LIMITED

2BIOCON BIOLOGICS INDIA LIMITED

3NIVIRA EXPORTS

4VAMA LIFECARE PRIVATE LIMITED

5R B INTERNATIONAL

6AMERICAN MIDDLE EASTERN MEDICAL SOLUTIONS PRIVATE

From Indian Factories to Global Pharmacies — How Ustekinumab Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Ustekinumab Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Brazil

2Japan

3Saudi Arabia

4Turkey

5United Arab Emirates

People Also Ask — Ustekinumab Supplier & Trade Network

Ustekinumab Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology